JP2002523361A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002523361A5 JP2002523361A5 JP2000565865A JP2000565865A JP2002523361A5 JP 2002523361 A5 JP2002523361 A5 JP 2002523361A5 JP 2000565865 A JP2000565865 A JP 2000565865A JP 2000565865 A JP2000565865 A JP 2000565865A JP 2002523361 A5 JP2002523361 A5 JP 2002523361A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- straight
- independently
- chain
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
Description
【請求項２】 式（Ｉ）の化合物において、Ｒ１及びＲ２は、それぞれ、独立して直鎖のＣ１〜１４−アルキル基又はＣ３〜１４−シクロアルキル基を表す、請求項１記載の医薬。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19838547.1 | 1998-08-25 | ||
| DE19838547 | 1998-08-25 | ||
| PCT/DE1999/002656 WO2000010543A2 (de) | 1998-08-25 | 1999-08-25 | Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002523361A JP2002523361A (ja) | 2002-07-30 |
| JP2002523361A5 true JP2002523361A5 (ja) | 2006-10-12 |
Family
ID=7878626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000565865A Pending JP2002523361A (ja) | 1998-08-25 | 1999-08-25 | 白金錯化合物含有医薬並びにその使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6881751B2 (ja) |
| EP (1) | EP1107751B1 (ja) |
| JP (1) | JP2002523361A (ja) |
| KR (1) | KR20010079680A (ja) |
| CN (1) | CN1224385C (ja) |
| AT (1) | ATE241975T1 (ja) |
| AU (1) | AU769882C (ja) |
| BR (1) | BR9913321A (ja) |
| CA (1) | CA2341701A1 (ja) |
| CZ (1) | CZ293449B6 (ja) |
| DE (2) | DE59905863D1 (ja) |
| DK (1) | DK1107751T3 (ja) |
| ES (1) | ES2201792T3 (ja) |
| HU (1) | HUP0103262A3 (ja) |
| IL (1) | IL141575A0 (ja) |
| MX (1) | MXPA01001999A (ja) |
| NO (1) | NO20010907L (ja) |
| NZ (1) | NZ509529A (ja) |
| PL (1) | PL346643A1 (ja) |
| PT (1) | PT1107751E (ja) |
| WO (1) | WO2000010543A2 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1391221A1 (en) * | 2002-08-23 | 2004-02-25 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| EP1541142A1 (en) * | 2003-12-10 | 2005-06-15 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Pharmaceutical compositions containing platinum complexes with secondary xanthates and therapeutic uses thereof |
| US20080193961A1 (en) * | 2004-09-29 | 2008-08-14 | Easley Christopher J | Localized Control of Thermal Properties on Microdevices and Applications Thereof |
| WO2006044458A2 (en) * | 2004-10-13 | 2006-04-27 | University Of Virginia Patent Foundation | Electrostatic actuation for management of flow |
| EP1859797A4 (en) * | 2005-02-28 | 2011-04-13 | Eisai R&D Man Co Ltd | NEW SIMULTANEOUS USE OF A SULPHONAMIDE COMPOUND AND A MEDIUM AGAINST CANCER |
| WO2007047336A2 (en) * | 2005-10-12 | 2007-04-26 | University Of Virginia Patent Foundation | Integrated microfluidic analysis systems |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4843161A (en) | 1984-06-01 | 1989-06-27 | Massachusetts Institute Of Technology | Platinum-intercalative complexes for the treatment of cancer |
| US4885376A (en) | 1987-10-13 | 1989-12-05 | Iowa State University Research Foundation, Inc. | New types of organometallic reagents and catalysts for asymmetric synthesis |
| US5068375A (en) | 1990-10-01 | 1991-11-26 | Exxon Research & Engineering Company | Substituted noble metal xanthates |
| ZA941290B (en) | 1993-02-26 | 1995-08-25 | Res Dev Foundation | Combination cisplatin/tamoxifen therapy for human cancers |
| US5844001A (en) | 1993-02-26 | 1998-12-01 | Research Development Foundation | Combination platinum chemotherapeutic/antiestrogen therapy for human cancers |
-
1999
- 1999-08-25 CZ CZ2001569A patent/CZ293449B6/cs not_active IP Right Cessation
- 1999-08-25 CN CNB998101141A patent/CN1224385C/zh not_active Expired - Fee Related
- 1999-08-25 KR KR1020017002273A patent/KR20010079680A/ko not_active Application Discontinuation
- 1999-08-25 NZ NZ509529A patent/NZ509529A/en unknown
- 1999-08-25 WO PCT/DE1999/002656 patent/WO2000010543A2/de not_active Application Discontinuation
- 1999-08-25 AT AT99953589T patent/ATE241975T1/de not_active IP Right Cessation
- 1999-08-25 JP JP2000565865A patent/JP2002523361A/ja active Pending
- 1999-08-25 DE DE59905863T patent/DE59905863D1/de not_active Expired - Lifetime
- 1999-08-25 HU HU0103262A patent/HUP0103262A3/hu unknown
- 1999-08-25 PT PT99953589T patent/PT1107751E/pt unknown
- 1999-08-25 CA CA002341701A patent/CA2341701A1/en not_active Abandoned
- 1999-08-25 MX MXPA01001999A patent/MXPA01001999A/es not_active IP Right Cessation
- 1999-08-25 DE DE19940407A patent/DE19940407A1/de not_active Withdrawn
- 1999-08-25 BR BR9913321-0A patent/BR9913321A/pt not_active IP Right Cessation
- 1999-08-25 PL PL99346643A patent/PL346643A1/xx unknown
- 1999-08-25 EP EP99953589A patent/EP1107751B1/de not_active Expired - Lifetime
- 1999-08-25 DK DK99953589T patent/DK1107751T3/da active
- 1999-08-25 ES ES99953589T patent/ES2201792T3/es not_active Expired - Lifetime
- 1999-08-25 AU AU10286/00A patent/AU769882C/en not_active Ceased
- 1999-10-25 IL IL14157599A patent/IL141575A0/xx unknown
-
2001
- 2001-02-15 US US09/784,618 patent/US6881751B2/en not_active Expired - Fee Related
- 2001-02-22 NO NO20010907A patent/NO20010907L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2017047I1 (no) | Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt | |
| JP2002511411A5 (ja) | ||
| JP2002525392A5 (ja) | ||
| JP2002060340A5 (ja) | ||
| WO2003037864A1 (fr) | Compose indolique, et utilisation a des fins therapeutiques | |
| NZ541974A (en) | Nucleotide phosphoramidates as anticancer agents | |
| WO2003037860A3 (en) | Purine analogs having hsp90-inhibiting activity | |
| JP2003510332A5 (ja) | ||
| RS50485B (sr) | Terapeutske kombinacije koje sadrže amplodipin i atorvastatin | |
| JP2006516528A5 (ja) | ||
| JP2000159790A5 (ja) | ||
| CA2413163A1 (en) | 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides | |
| WO2009064374A8 (en) | Oral formulations of bis(thiohydrazide amides) | |
| ITTO20000281A0 (it) | Gruppo d'assemblaggio per cursore-linguetta di trazione di una cerniera lampo. | |
| WO2002032901A3 (en) | Bridged piperazine derivatives | |
| JP2002522501A5 (ja) | ||
| JP2001513504A5 (ja) | ||
| JP2002523361A5 (ja) | ||
| EP1544194A4 (en) | DERIVATIVE 4- (ARYL SUBSTITUTED) -5-HYDROXYISOQUINOLINONE | |
| JP2006525972A5 (ja) | ||
| AU1650501A (en) | 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient | |
| EP1026162A4 (en) | ANTI-RHUMATISMAL AGENT | |
| WO2003024941A1 (fr) | Composes de naphtalene et leur utilisation comme medicament | |
| JP2002535406A5 (ja) | ||
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents |